Skip to main content
Fig. 2 | International Journal of Retina and Vitreous

Fig. 2

From: Visual and anatomical outcomes associated with treat-and-extend administration of intravitreal aflibercept for neovascular age-related macular degeneration

Fig. 2

Mean best-corrected visual acuity (BCVA) as logarithm of the minimal angle of resolution units (A) and central retinal thickness (B) as a function of intravitreal aflibercept treatment duration. Errors bars correspond to 95% confidence intervals that extend two standard errors above and below the mean. p  <  0.001 (***), p  <  0.01 (**), p  <  0.05 (*), non-significant (NS)

Back to article page